1-5 of 5
Rui Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Designed Anti–PD-L1/OX40 Bispecific Antibody Augments Both Peripheral and Tumor-Associated Immune Responses for Boosting Antitumor Immunity

Baocun Li, Shiyong Gong, Nianying Zhang, Beilei Shi, Zhou Lv, Yu Zhang, Naren Gaowa, Liqin Dong, Danqing Wu, Jianfu Wu, Fan Liu, Rui Zhang, Ramin Behzadigohar, Vinod Ganju, Chengbin Wu, Xuan Wu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF14.
https://doi.org/10.1158/1535-7163.MCT-24-0330
Published: 09 December 2024
View article titled, A Novel Designed Anti–PD-L1/OX40 Bispecific Antibody Augments Both Peripheral and Tumor-Associated Immune Responses for Boosting Antitumor Immunity
Open the PDF for A Novel Designed Anti–PD-L1/OX40 Bispecific Antibody Augments Both Peripheral and Tumor-Associated Immune Responses for Boosting Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

BRAFV600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis

Chan-Juan Wang, Lei Cui, Hong-Hao Ma, Dong Wang, Li Zhang, Hong-Yun Lian, Wei-Jing Li, Qing Zhang, Tian-You Wang, Zhi-Gang Li, Rui Zhang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (7): 1316–1323.
https://doi.org/10.1158/1535-7163.MCT-20-1075
Published: 01 July 2021
View article titled, <em>BRAF</em><sup>V600E</sup> Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis
Open the PDF for <em>BRAF</em><sup>V600E</sup> Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis in another window
Includes: Supplementary data
Journal Articles

Abstract B142: Co-culture of tumor organoids with immune cells for immuno-oncology drug development

Zhongliang Li, Jun Zhou, Rui Zhang, Fei Wang, Shuzong Wang, Xiaoxi Xu, Yujun Huang, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): B142.
https://doi.org/10.1158/1535-7163.TARG-19-B142
Published: 01 December 2019
View article titled, Abstract B142: Co-culture of tumor organoids with immune cells for immuno-oncology drug development
Journal Articles

Abstract B59: Zhangfei/CREBZF arrests the growth of osteosarcoma cells by displacing Mdm2 and stabilizing p53.

Rui Zhang, Vikram Misra
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B59.
https://doi.org/10.1158/1535-7163.TARG-13-B59
Published: 01 November 2013
View article titled, Abstract B59: Zhangfei/CREBZF arrests the growth of osteosarcoma cells by displacing Mdm2 and stabilizing p53.
Journal Articles

In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy

Marites P. Melancon, Wei Lu, Zhi Yang, Rui Zhang, Zhi Cheng, Andrew M. Elliot, Jason Stafford, Tammy Olson, Jin Z. Zhang, Chun Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (6): 1730–1739.
https://doi.org/10.1158/1535-7163.MCT-08-0016
Published: 19 June 2008
View article titled, <em>In vitro</em> and <em>in vivo</em> targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy
Open the PDF for <em>In vitro</em> and <em>in vivo</em> targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy in another window